An Economic Evaluation of the Triple HCV Treatment Regimen for G1 Naïve Patients in the Greek Health Care System

Value in Health - United Kingdom
doi 10.1016/j.jval.2013.08.1113
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Economic Evaluation of Abbvie’s Regimen (Viekirax/Exviera) for Patients With Genotype 1a HCV in Greece

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Php40 Health Care Reforms Under Economic Crisis: The Greek Case

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Naturally Occurring Mutations to HCV Protease Inhibitors in Treatment-Naïve Patients

Virology Journal
VirologyInfectious Diseases
2012English

Evaluation of the Efficacy of Triple Therapy Regimen for Helicobacter Pylori Eradication in Gastrectomized Patients With Gastric Adenocarcinoma

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2006English

Economic Evaluation of Health Care Utilization in the Slovak Republic

CBU International Conference Proceedings
2016English

Economic Evaluation of ASCOT-BPLA: Antihypertensive Treatment With an Amlodipine-Based Regimen Is Cost Effective Compared With an Atenolol-Based Regimen

Heart
Cardiovascular MedicineCardiology
2008English

PSY36 Economic Evaluation of Pegvisomant for Active Acromegaly Patients Who Failed Available Therapies in Brazil – Public Health Care System Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Reasons and Risk Factors for the Initial Regimen Modification in Chinese Treatment-Naïve Patients With HIV Infection: A Retrospective Cohort Analysis

PLoS ONE
Multidisciplinary
2015English

Economic Justification of Coordinated Care Program for the University of Missouri Health Care System

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy